CLINICAL_TRIALS
trial_result
· 2013-12-19
Clinical Trial Update: The Efficacy and Tolerability of Duloxetine for the Treatment of Panic Disorder [Phase 4]
Summary
Phase 4 trial evaluating the efficacy and tolerability of duloxetine for panic disorder has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Panic Disorder | Phase 4 | Status: COMPLETED | Results posted: 2013-12-19